I don’t know where else you would find an investment bank with such expertise. They could move from financial and strategic discussions to highly scientific, clinical discussions with ease. In the end, they brought all these perspectives to bear, developing an exceptional strategy that created value for our company.
Outcome Capital has demonstrated an astute and insightful understanding of our value proposal and the major companies in the cardiovascular space. They provided us with invaluable strategic advice and I can’t think of better partners to have guided us through the process.
They understood our technology and business as well as anyone.
Outcome worked diligently with our executives and board to develop and communicate a strategy that was instrumental in enhancing the value of our company. Their business acumen and knowledge of our market space drove a complex transaction to a very successful close.
Advanced Uro-Solutions engaged the services of Outcome Capital late in the process of being acquired. Outcome Capital took control of all further negotiations and masterfully increased the value of our final offering. The added value Outcome Capital was responsible for was 10 times greater than the value we invested in their services. Our only regret was in not bringing them on sooner. Arnie and Oded brought an amazing team of talented, organized and highly effective individuals. We could NOT have been more satisfied.
With the assistance of Outcome’s recognized expertise in the biomedical field, GenePOC was able to devise and communicate a market-aligned strategy leading to the completion a transaction efficiently and effectively. We are very pleased with the way Outcome supported us throughout this process.
I thank the Outcome team for driving the Verrix acquisition to completion, for protecting our interests and for an excellent job in navigating the bumps along the way. The Outcome team ran a solid competitive process that caused the market to speak toward a transaction for the benefit of both buyer and seller.
As a dedicated life sciences investment banking group, Outcome leveraged their industry knowledge in positioning BHA in the market and deftly communicated the value we offer our clients to our transaction partner. Their ability to execute alone was worth their value, considering the volume of work they took on, but as a CEO it was their patient demeanor balanced by their tenacious attitude that I will remember and benefitted from most. By the end of the transaction, I was thankful for each member of our deal team at Outcome Capital and the value they offered.
The healthcare system must balance the demands of its many stakeholders, including patients, insurers, and providers. Recent technology advances present an opportunity to make healthcare more efficient and accessible – from increasing data collection to improving analytics/diagnosis to coordinating and delivering care virtually. The Outcome Capital Healthcare team is dedicated to understanding the many intricacies and ongoing advancements to anticipate segment trends dynamics. The healthcare operational experience of Outcome professionals enables effective positioning to maximize value for their clients across M&A, capital raise and advisory services.